Rebecca Hoh

发表

Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool

Reshma Kassanjee, Oliver Laeyendecker, Barbara Suligoi, 2019, BMC Infectious Diseases.

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

Michael P. Busch, Jun Lai, John W. Mellors, 2018, bioRxiv.

Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.

Wei Huang, Rebecca Hoh, Torsten B Neilands, 2007, The Journal of infectious diseases.

Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists.

Qianjun Zhang, Rebecca Hoh, J. McCune, 2012, Blood.

Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.

Eoin Coakley, Rebecca Hoh, Peter Hunt, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Rebecca Hoh, Peter Bacchetti, Matthew C Strain, 2013, The Journal of infectious diseases.

Viral Dynamics and In Vivo Fitness of HIV-1 in the Presence and Absence of Enfuvirtide

Sebastian Bonhoeffer, Rebecca Hoh, Roger Paredes, 2008, Journal of acquired immune deficiency syndromes.

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Rebecca Hoh, Wendy Hartogensis, Peter Bacchetti, 2015, The lancet. HIV.

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

Rebecca Hoh, Torsten B Neilands, Robert M Grant, 2005, The Journal of infectious diseases.

Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses

Christos J. Petropoulos, Terri Wrin, Steven G. Deeks, 2006, Journal of Virology.

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response

Terri Wrin, Rebecca Hoh, Robert M Grant, 2003, AIDS.

Rapid Emergence of Enfuvirtide Resistance in HIV-1-Infected Patients: Results of a Clonal Analysis

Rebecca Hoh, Daniel R Kuritzkes, Jeffrey N. Martin, 2006, Journal of acquired immune deficiency syndromes.

Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease.

Marc A Suchard, Rebecca Hoh, Daniel R Kuritzkes, 2006, AIDS research and human retroviruses.